Simulated Training: Talk About OUD with Your Patients

Talk About Opioid Use Disorder with Your Patients: A Clinical Practice Simulation is a 30-minute interactive case-based training simulation offering best practices and evidence-based communication strategies to better equip primary care providers to address the needs of patients with opioid use disorder (OUD).
This simulation targets primary care clinicians, and will offer information about the opioid crisis, the neurobiology of OUD, the effectiveness of medication, and treating patients with OUD with empathy. The simulation is grounded in real-world experiences and will capture the participant’s decision points and performance; provide real-time feedback to participants on their decisions, errors, and missed steps; and proceed based on decisions by the participant during the simulation.
Please click the blue “Begin Simulation” button below to access the “Clinical Practice Simulation”.
PCSS has partnered with Kognito, a health simulation company, to make this training available.
Assessment Information
In the simulated conversation in this activity, you’ll be asked to make several decisions. You’ll have multiple attempts to make the correct decisions, and will need to retry specific decisions if your choices are not successful. You will be evaluated on your performance as you proceed through the simulation, and you will be able to view a summary of your choices on a performance dashboard. In addition, you will be asked to complete a short online survey about your experience in the training.
Purpose of Activity
As a result of completing this activity, clinicians should be better able to:
  • Recognize people with OUD as patients in need of help.
  • Reject outdated and moralistic beliefs about “addicts” and “addiction.”
  • Understand the medications available to treat OUD and their effectiveness.
  • Use shared decision making and motivational approaches to help people with OUD engage in healthier behavior and begin recovery through treatment
  • Seek a DATA-2000 waiver and/or use buprenorphine to treat patients in an office setting.

Continuing Education Information

Continuing Medical Education
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The University of Arizona College of Medicine – Tucson and Kognito Solutions LLC. The University of Arizona College of Medicine at the Arizona Health Sciences Center is accredited by the ACCME to provide continuing medical education for physicians.
Designation Statement
The University of Arizona College of Medicine – Tucson designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
This continuing nursing education activity was approved by Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center’s Commission on Accreditation. To receive a certificate of completion, users must:
  • Attend the entire activity
  • Complete the activity evaluation form
The Montana Nurses Association designates the activity entitled “Talk about Opioid Use Disorder with Your Patients: A Clinical Practice Simulation” for 0.75 total contact hours of continuing nursing education.
This activity is approved from 10/8/18 – 10/8/20.
This activity was jointly provided with Providers Clinical Support System.
Simulation Acknowledgement:
This simulation course was prepared with support through Contract No. HHSS283201200002I/HHSS28342009T, Reference No. 283-12-0209 with the Substance Abuse and Mental Health Services Administration (SAMHSA), U.S. Department of Health and Human Services (HHS). Nothing in this simulation constitutes a direct or indirect endorsement by SAMSHA or HHS of any non-federal entity’s products, services, or policies, and any reference to non-federal entity’s products, services, or policies should not be construed as such.
Look for more information about treating chronic pain and opioid use disorder and additional trainings at
PCSS Acknowledgement:
Funding for this initiative was made possible (in part) by grant no. 5U79TI026556-03 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.